Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 177 Observational 51 Expanded_access 1

Sponsor

Cancer Type

Conditions

Neoplasms 37 Carcinoma, Non-Small-Cell Lung 34 Multiple Myeloma 32 Recurrence 29 Prostatic Neoplasms 28 Melanoma 21 Leukemia, Myeloid, Acute 21 Breast Neoplasms 18 Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Glioblastoma 15 Pancreatic Neoplasms 14 Sarcoma 13 Neuroblastoma 13 Lymphoma 13 Glioma 11 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10 Leukemia 10 Ovarian Neoplasms 9 Lung Neoplasms 9 Colorectal Neoplasms 9 Carcinoma, Hepatocellular 9 Small Cell Lung Carcinoma 8 Lymphoma, Large B-Cell, Diffuse 8 Lambert-Eaton Myasthenic Syndrome 8 Pheochromocytoma 7 Neuroendocrine Tumors 7 Neoplasm Metastasis 7 Lymphoma, Non-Hodgkin 7 Gastrointestinal Stromal Tumors 7 Carcinoma, Renal Cell 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × Meningioma × Clear all

NCT07497984 2026-03-27

ITM11 Expanded Access Program

ITM Solucin GmbH

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡